Literature DB >> 10189836

Matrix metalloproteinases in gastrointestinal cancer.

P D Brown1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10189836      PMCID： PMC1727209          DOI： 10.1136/gut.43.2.161

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  28 in total

1.  Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer.

Authors:  S Zucker; R M Lysik; B I DiMassimo; H M Zarrabi; U M Moll; R Grimson; S P Tickle; A J Docherty
Journal:  Cancer       Date:  1995-08-15       Impact factor: 6.860

2.  Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors.

Authors:  M Murashige; M Miyahara; N Shiraishi; T Saito; K Kohno; M Kobayashi
Journal:  Jpn J Clin Oncol       Date:  1996-10       Impact factor: 3.019

3.  Matrilysin is associated with progression of colorectal tumor.

Authors:  T Ishikawa; Y Ichikawa; M Mitsuhashi; N Momiyama; T Chishima; K Tanaka; H Yamaoka; K Miyazakic; Y Nagashima; T Akitaya; H Shimada
Journal:  Cancer Lett       Date:  1996-10-01       Impact factor: 8.679

4.  Expression of membrane-type matrix metalloproteinase in human gastric carcinomas.

Authors:  H Nomura; H Sato; M Seiki; M Mai; Y Okada
Journal:  Cancer Res       Date:  1995-08-01       Impact factor: 12.701

5.  Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer.

Authors:  N B Liabakk; I Talbot; R A Smith; K Wilkinson; F Balkwill
Journal:  Cancer Res       Date:  1996-01-01       Impact factor: 12.701

6.  Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer.

Authors:  G I Murray; M E Duncan; P O'Neil; W T Melvin; J E Fothergill
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

7.  Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models.

Authors:  S A Watson; T M Morris; G Robinson; M J Crimmin; P D Brown; J D Hardcastle
Journal:  Cancer Res       Date:  1995-08-15       Impact factor: 12.701

8.  Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.

Authors:  C F Sier; F J Kubben; S Ganesh; M M Heerding; G Griffioen; R Hanemaaijer; J H van Krieken; C B Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

9.  Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.

Authors:  Z S Zeng; J G Guillem
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

10.  Similarities of in situ mRNA expression between gelatinase A (MMP-2) and type I procollagen in human gastrointestinal carcinoma: comparison with granulation tissue reaction.

Authors:  H Ohtani; T Nagai; H Nagura
Journal:  Jpn J Cancer Res       Date:  1995-09
View more
  12 in total

Review 1.  Myofibroblasts: paracrine cells important in health and disease.

Authors:  D W Powell
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

Review 2.  Matrix metalloproteinase inhibitors: applications in oncology.

Authors:  D Yip; A Ahmad; C S Karapetis; C A Hawkins; P G Harper
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

3.  Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.

Authors:  Sheng Zhang; Li Li; Jian-Yin Lin; Hua Lin
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

4.  Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.

Authors:  B von Lampe; B Barthel; S E Coupland; E O Riecken; S Rosewicz
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

5.  Lithocholic acid and sulphated lithocholic acid differ in the ability to promote matrix metalloproteinase secretion in the human colon cancer cell line CaCo-2.

Authors:  B Halvorsen; A C Staff; S Ligaarden; K Prydz; S O Kolset
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

6.  Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation.

Authors:  M T Salmela; T T MacDonald; D Black; B Irvine; T Zhuma; U Saarialho-Kere; S L F Pender
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

7.  Inflammatory responses induced by interleukin-17 family members in human colonic subepithelial myofibroblasts.

Authors:  Yuhki Yagi; Akira Andoh; Osamu Inatomi; Tomoyuki Tsujikawa; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

8.  Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley.

Authors:  Manzoor A Malik; Kiran L Sharma; Showket A Zargar; Balraj Mittal
Journal:  Saudi J Gastroenterol       Date:  2011 Sep-Oct       Impact factor: 2.485

9.  mRNA profiling of the cancer degradome in oesophago-gastric adenocarcinoma.

Authors:  J P Baren; G D Stewart; A Stokes; K Gray; C J Pennington; R O'Neill; D A C Deans; S Paterson-Brown; A C P Riddick; D R Edwards; K C H Fearon; J A Ross; R J E Skipworth
Journal:  Br J Cancer       Date:  2012-06-07       Impact factor: 7.640

10.  Calibrating models of cancer invasion: parameter estimation using approximate Bayesian computation and gradient matching.

Authors:  Yunchen Xiao; Len Thomas; Mark A J Chaplain
Journal:  R Soc Open Sci       Date:  2021-06-16       Impact factor: 2.963
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.